Long-term outcomes of 107 patients with myelofibrosis receiving JAK1/JAK2 inhibitor ruxolitinib: survival advantage in comparison to matched historical controls. (Record no. 21882582)

MARC details
000 -LEADER
fixed length control field 02405 a2200661 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516100132.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201210s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1528-0020
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1182/blood-2012-02-414631
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Verstovsek, Srdan
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20121025
245 00 - TITLE STATEMENT
Title Long-term outcomes of 107 patients with myelofibrosis receiving JAK1/JAK2 inhibitor ruxolitinib: survival advantage in comparison to matched historical controls.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Blood
Date of publication, distribution, etc. Aug 2012
300 ## - PHYSICAL DESCRIPTION
Extent 1202-9 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Comparative Study; Evaluation Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Case-Control Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clinical Trials, Phase I as Topic
General subdivision statistics & numerical data
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clinical Trials, Phase II as Topic
General subdivision statistics & numerical data
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clinical Trials, Phase III as Topic
General subdivision statistics & numerical data
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cohort Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Follow-Up Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Janus Kinase 1
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Janus Kinase 2
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nitriles
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Primary Myelofibrosis
General subdivision diagnosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Kinase Inhibitors
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrazoles
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrimidines
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Randomized Controlled Trials as Topic
General subdivision statistics & numerical data
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Survival Analysis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Survivors
General subdivision statistics & numerical data
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Assessment of Medication Adherence
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kantarjian, Hagop M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Estrov, Zeev
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cortes, Jorge E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Thomas, Deborah A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kadia, Tapan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pierce, Sherry
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jabbour, Elias
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Borthakur, Gautham
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rumi, Elisa
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pungolino, Ester
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Morra, Enrica
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Caramazza, Domenica
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cazzola, Mario
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Passamonti, Francesco
773 0# - HOST ITEM ENTRY
Title Blood
Related parts vol. 120
-- no. 6
-- p. 1202-9
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1182/blood-2012-02-414631">https://doi.org/10.1182/blood-2012-02-414631</a>
Public note Available from publisher's website

No items available.